Vascular endothelial growth factor in Coats' disease

Area of Science:

• Ophthalmology
• Vascular Biology
• Cytokine Research

Background:

• Coats' disease is characterized by abnormal blood vessel development and leakage.
• Vascular Endothelial Growth Factor (VEGF) is a key cytokine involved in angiogenesis and vascular permeability.
• The role of intraocular VEGF in Coats' disease pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the association between intraocular vascular endothelial growth factor (VEGF) concentrations and Coats' disease.
• To determine if VEGF levels correlate with the severity and stage of Coats' disease.

Main Methods:

• A clinical interventional study involving 28 patients with Coats' disease and 7 controls.
• Aqueous humor samples were collected during intraocular surgery.
• VEGF concentrations were quantified using enzyme-linked immunosorbent assay (ELISA).
• Coats' disease was staged, and VEGF levels were correlated with disease stage and retinal detachment extent.

Main Results:

• Mean aqueous VEGF levels were significantly higher in Coats' disease patients compared to controls (158±88 vs. 97±21 pg/ml, p=0.002).
• VEGF concentrations showed a significant increase with advancing stages of Coats' disease (p<0.001).
• VEGF levels correlated significantly with the extent of exudative retinal detachment (p<0.001).

Conclusions:

• Intraocular VEGF concentrations are significantly associated with the severity of Coats' disease.
• Elevated VEGF levels in Coats' disease support the potential therapeutic use of anti-VEGF agents.
• Intravitreal anti-VEGF therapy is a promising medical treatment option for Coats' disease.